Alterola Biotech, Inc.: 10-K filed 2018-12-17

Name: Alterola Biotech, Inc.: 10-K filed 2018-12-17
Creator: Alterola Biotech, Inc.

What Alterola Biotech, Inc. reported in its annual report filed 2018-12-17 (fiscal FY 2017): 18 published measures, 35 facts as tagged in accession 0001663577-18-000560.

This filing

Form: 10-K (annual report)
Filed: 2018-12-17
Fiscal period: fiscal FY 2017
Accession: 0001663577-18-000560 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Alterola Biotech, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-09-30	2,583	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2017-09-30	-294,678	USD
At 2016-09-30	-264,046	USD
At 2015-09-30	-241,469	USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2016-10-01 to 2017-09-30	0	USD	365
2015-10-01 to 2016-09-30	-27,631	USD	366

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2016-10-01 to 2017-09-30	0	USD	365
2015-10-01 to 2016-09-30	0	USD	366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2016-10-01 to 2017-09-30	0	USD	365
2015-10-01 to 2016-09-30	25,000	USD	366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-09-30	-579,508	USD
At 2016-09-30	-511,876	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2016-10-01 to 2017-09-30	37,000	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2016-10-01 to 2017-09-30	-49,132	USD	365
2015-10-01 to 2016-09-30	-14,731	USD	366

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2016-10-01 to 2017-09-30	18,500	USD	365
2015-10-01 to 2016-09-30	18,019	USD	366

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-09-30	294,678	USD
At 2016-09-30	266,629	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2016-10-01 to 2017-09-30	49,132	USD	365
2015-10-01 to 2016-09-30	14,731	USD	366

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-09-30	169,850	USD
At 2016-09-30	132,850	USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2017-09-30	175,000	USD
At 2016-09-30	175,000	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2017-09-30	20,900	USD
At 2016-09-30	11,351	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2016-10-01 to 2017-09-30	-67,632	USD	365
2015-10-01 to 2016-09-30	-22,577	USD	366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2016-10-01 to 2017-09-30	341	USD	365
2015-10-01 to 2016-09-30	2,318	USD	366

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2016-10-01 to 2017-09-30	-18,500	USD	365
2015-10-01 to 2016-09-30	-7,846	USD	366

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

Period	Value	Unit	Days
2016-10-01 to 2017-09-30	0	USD	365
2015-10-01 to 2016-09-30	0	USD	366

Inspect the source

Entity: Alterola Biotech, Inc. / CIK 0001442999
Captured: 2026-09-21T17:19:50.475Z
SEC response SHA-256: 87a3a16f9156f52960516ff7604a147caa80abebfe964591df0bd913491df844

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001442999.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))